These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11077730)

  • 1. [Effect of temperature on drug solubility in complex formation of flubendazole and 2-hydroxypropyl-beta-cyclodextrin].
    Vetchý D; Rabisková M; Sucman E
    Ceska Slov Farm; 2000 Sep; 49(5):239-41. PubMed ID: 11077730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubility, 1H-NMR, and molecular mechanics of mebendazole with different cyclodextrins.
    Díaz D; Bernad Bernad MJ; Gracia-Mora J; Escobar Llanos CM
    Drug Dev Ind Pharm; 1999 Jan; 25(1):111-5. PubMed ID: 10028428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution.
    Ceballos L; Moreno L; Torrado JJ; Lanusse C; Alvarez L
    BMC Vet Res; 2012 May; 8():71. PubMed ID: 22640491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the potential of flubendazole in filariasis control: evaluation of the systemic exposure for different pharmaceutical preparations.
    Ceballos L; Mackenzie C; Geary T; Alvarez L; Lanusse C
    PLoS Negl Trop Dis; 2014; 8(5):e2838. PubMed ID: 24874646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral bioavailability enhancement of flubendazole by developing nanofibrous solid dosage forms.
    Vigh T; Démuth B; Balogh A; Galata DL; Van Assche I; Mackie C; Vialpando M; Van Hove B; Psathas P; Borbás E; Pataki H; Boeykens P; Marosi G; Verreck G; Nagy ZK
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1126-1133. PubMed ID: 28274133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of the inclusion complex of furosemide with hydroxypropyl-beta-cyclodextrin.
    Vlachou M; Papaïoannou G
    J Biomater Appl; 2003 Jan; 17(3):197-206. PubMed ID: 12614084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermodynamic study of cyclodextrins complexation with benzimidazolic antihelmintics in different reaction media.
    Bernad-Bernad MJ; Gracia-Mora J; Díaz D; Castillo-Blum SE
    Curr Drug Discov Technol; 2008 Jun; 5(2):146-53. PubMed ID: 18673253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprophylactic activity of flubendazole in cystic echinococcosis.
    Ceballos L; Elissondo C; Sánchez Bruni S; Confalonieri A; Denegri G; Alvarez L; Lanusse C
    Chemotherapy; 2010; 56(5):386-92. PubMed ID: 20948209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of natamycin:cyclodextrin inclusion complexes and their characterization.
    Koontz JL; Marcy JE
    J Agric Food Chem; 2003 Nov; 51(24):7106-10. PubMed ID: 14611179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 2-hydroxypropyl-beta-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17 beta-estradiol.
    Loftsson T; Bodor N
    Acta Pharm Nord; 1989; 1(4):185-94. PubMed ID: 2590460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban: formation of aggregates and higher-order complexes.
    Duan MS; Zhao N; Ossurardóttir IB; Thorsteinsson T; Loftsson T
    Int J Pharm; 2005 Jun; 297(1-2):213-22. PubMed ID: 15885935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubilization of vorinostat by cyclodextrins.
    Cai YY; Yap CW; Wang Z; Ho PC; Chan SY; Ng KY; Ge ZG; Lin HS
    J Clin Pharm Ther; 2010 Oct; 35(5):521-6. PubMed ID: 20831676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclodextrins as solubilizers: formation of complex aggregates.
    Jansook P; Kurkov SV; Loftsson T
    J Pharm Sci; 2010 Feb; 99(2):719-29. PubMed ID: 19670293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of griseofulvin with cyclodextrins in solid binary systems.
    Veiga MD; Díaz PJ; Ahsan F
    J Pharm Sci; 1998 Jul; 87(7):891-900. PubMed ID: 9649360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubilization of the neutral and charged forms of 2,4,6-trichlorophenol by hydroxypropyl-beta-cyclodextrin, or methyl-beta-cyclodextrin in water.
    He Y; Yalkowsky SH
    J Hazard Mater; 2004 Apr; 108(1-2):129-31. PubMed ID: 15081172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the electrokinetic properties on the stability of mebendazole suspensions for veterinary applications.
    Cózar-Bernal MJ; Gallardo V; Sáez-Fernández E; Holgado MA; Alvarez-Fuentes J; Fernández-Arévalo M; Arias JL
    Int J Pharm; 2010 Jun; 393(1-2):161-6. PubMed ID: 20435113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the complexation of albendazole with cyclodextrins for the design of new antiparasitic formulations.
    Pradines B; Gallard JF; Iorga BI; Gueutin C; Loiseau PM; Ponchel G; Bouchemal K
    Carbohydr Res; 2014 Oct; 398():50-5. PubMed ID: 25240182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of aqueous parenteral formulations for carbamazepine through the use of modified cyclodextrins.
    Brewster ME; Anderson WR; Estes KS; Bodor N
    J Pharm Sci; 1991 Apr; 80(4):380-3. PubMed ID: 1865340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxypropyl cyclodextrins: potential synergism with carcinogens.
    Horský J; Pitha J
    J Pharm Sci; 1996 Jan; 85(1):96-100. PubMed ID: 8926593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of water-soluble polymers on naproxen complexation with natural and chemically modified beta-cyclodextrins.
    Faucci MT; Mura P
    Drug Dev Ind Pharm; 2001 Oct; 27(9):909-17. PubMed ID: 11763468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.